Rajesh M et al. |
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. |
2012 |
Diabetes |
pmid:22315315
|
Troy-Fioramonti S et al. |
Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice. |
2015 |
Diabetes |
pmid:25281429
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Mallat A and Lotersztajn S |
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. |
2008 |
Diabetes Metab. |
pmid:19195630
|
Eckardt K et al. |
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. |
2009 |
Diabetologia |
pmid:19089403
|
Harada N and Okajima K |
Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats. |
2007 |
Dig. Dis. Sci. |
pmid:17211693
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Childers SR and Breivogel CS |
Cannabis and endogenous cannabinoid systems. |
1998 Jun-Jul |
Drug Alcohol Depend |
pmid:9716939
|
Welch SP |
Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems. |
1997 |
Drug Alcohol Depend |
pmid:9179505
|
Muccioli GG |
Endocannabinoid biosynthesis and inactivation, from simple to complex. |
2010 |
Drug Discov. Today |
pmid:20304091
|
Farrell EK and Merkler DJ |
Biosynthesis, degradation and pharmacological importance of the fatty acid amides. |
2008 |
Drug Discov. Today |
pmid:18598910
|
Sridar C et al. |
Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. |
2011 |
Drug Metab. Dispos. |
pmid:21289075
|
Pratt-Hyatt M et al. |
Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. |
2010 |
Drug Metab. Dispos. |
pmid:20702771
|
Ekins S et al. |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. |
2007 |
Drug Metab. Dispos. |
pmid:17194716
|
Jia Y et al. |
TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. |
2005 |
Drug News Perspect. |
pmid:15915217
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Battista N et al. |
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24218186
|
Maingret F et al. |
The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. |
2001 |
EMBO J. |
pmid:11226154
|
Chemin J et al. |
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. |
2001 |
EMBO J. |
pmid:11742980
|
van der Stelt M et al. |
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. |
2005 |
EMBO J. |
pmid:16107881
|
Laezza C et al. |
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. |
2010 |
Endocr. Relat. Cancer |
pmid:20304978
|
Karlsson C et al. |
Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats. |
2015 |
Endocrinology |
pmid:25549047
|
Francavilla F et al. |
Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. |
2009 |
Endocrinology |
pmid:19608651
|
Forner-Piquer I et al. |
Dose-Specific Effects of Di-Isononyl Phthalate on the Endocannabinoid System and on Liver of Female Zebrafish. |
2017 |
Endocrinology |
pmid:28938452
|
Maccarrone M et al. |
Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. |
2003 |
Endocrinology |
pmid:12488326
|
Rossi G et al. |
Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. |
2007 |
Endocrinology |
pmid:17110429
|
Martella A et al. |
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop. |
2016 |
Endocrinology |
pmid:27014939
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Habayeb OM et al. |
Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. |
2008 |
Endocrinology |
pmid:18599552
|
Romigi A et al. |
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. |
2010 |
Epilepsia |
pmid:19817812
|
Manna SS and Umathe SN |
Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures. |
2012 |
Epilepsy Res. |
pmid:22386872
|
Citraro R et al. |
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. |
2013 |
Epilepsy Res. |
pmid:23860329
|
Schaefer C et al. |
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. |
2014 |
Eur Arch Psychiatry Clin Neurosci |
pmid:24253425
|
Moloney GP et al. |
Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. |
2008 |
Eur J Med Chem |
pmid:17582659
|
Ortar G et al. |
Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. |
2008 |
Eur J Med Chem |
pmid:17452063
|
López-RodrÃguez ML et al. |
Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. |
2003 |
Eur J Med Chem |
pmid:12750028
|
Bonechi C et al. |
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors. |
2006 |
Eur J Med Chem |
pmid:16837109
|
Cano C et al. |
Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. |
2009 |
Eur J Med Chem |
pmid:19762126
|
Monteleone AM et al. |
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. |
2016 |
Eur J Nutr |
pmid:26759262
|
Ford GK et al. |
Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats. |
2015 |
Eur J Pain |
pmid:25504741
|
Juntunen J et al. |
Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide. |
2003 |
Eur J Pharm Sci |
pmid:12729860
|
Karlsson M et al. |
Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. |
2004 |
Eur J Pharm Sci |
pmid:15158903
|
McLaughlin RJ et al. |
Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. |
2012 |
Eur Neuropsychopharmacol |
pmid:22325231
|
Manduca A et al. |
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats. |
2015 |
Eur Neuropsychopharmacol |
pmid:25914159
|
de Lago E et al. |
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. |
2006 |
Eur Neuropsychopharmacol |
pmid:16006105
|
Ellgren M et al. |
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. |
2008 |
Eur Neuropsychopharmacol |
pmid:18674887
|
Kaufmann I et al. |
Enhanced anandamide plasma levels in patients with complex regional pain syndrome following traumatic injury: a preliminary report. |
2009 |
Eur Surg Res |
pmid:19729930
|
Quercioli A et al. |
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. |
2011 |
Eur. Heart J. |
pmid:21303779
|
Raichlen DA et al. |
Exercise-induced endocannabinoid signaling is modulated by intensity. |
2013 |
Eur. J. Appl. Physiol. |
pmid:22990628
|
Feuerecker M et al. |
Effects of exercise stress on the endocannabinoid system in humans under field conditions. |
2012 |
Eur. J. Appl. Physiol. |
pmid:22101870
|
Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Van Der Stelt M and Di Marzo V |
Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. |
2004 |
Eur. J. Biochem. |
pmid:15128293
|
MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
Fasia L et al. |
Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? |
2003 |
Eur. J. Biochem. |
pmid:12919314
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Salzet M et al. |
Comparative biology of the endocannabinoid system possible role in the immune response. |
2000 |
Eur. J. Biochem. |
pmid:10931174
|
Sugiura T et al. |
Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. |
1996 |
Eur. J. Biochem. |
pmid:8797835
|
Matias I et al. |
Presence and regulation of the endocannabinoid system in human dendritic cells. |
2002 |
Eur. J. Biochem. |
pmid:12153574
|
Kapoor S |
Modulation of intracellular pathways by anandamide and its evolving role in oncology. |
2013 |
Eur. J. Cancer |
pmid:23434147
|
Laezza C et al. |
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. |
2013 |
Eur. J. Cancer |
pmid:23434151
|
Rossi C et al. |
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. |
2008 |
Eur. J. Clin. Pharmacol. |
pmid:18004553
|
Di Marzo V et al. |
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. |
2009 |
Eur. J. Endocrinol. |
pmid:19745037
|
Adermark L et al. |
Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. |
2009 |
Eur. J. Neurosci. |
pmid:19120438
|
Millns PJ et al. |
Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. |
2006 |
Eur. J. Neurosci. |
pmid:17229097
|
Sharkey KA et al. |
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. |
2007 |
Eur. J. Neurosci. |
pmid:17459108
|
Ryan D et al. |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. |
2007 |
Eur. J. Neurosci. |
pmid:17419758
|
Ahluwalia J et al. |
Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. |
2003 |
Eur. J. Neurosci. |
pmid:12823468
|
Sagan S et al. |
Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. |
1999 |
Eur. J. Neurosci. |
pmid:10051770
|
Cippitelli A et al. |
The anandamide transport inhibitor AM404 reduces ethanol self-administration. |
2007 |
Eur. J. Neurosci. |
pmid:17650118
|
Ali AB and Todorova M |
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. |
2010 |
Eur. J. Neurosci. |
pmid:20345910
|
Lemak MS et al. |
Cannabinoid regulation in identified synapse of terrestrial snail. |
2007 |
Eur. J. Neurosci. |
pmid:18028114
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Rivera P et al. |
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. |
2013 |
Eur. J. Neurosci. |
pmid:23033907
|
Sousa-Valente J et al. |
Anandamide in primary sensory neurons: too much of a good thing? |
2014 |
Eur. J. Neurosci. |
pmid:24494681
|
Rea K et al. |
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. |
2014 |
Eur. J. Neurosci. |
pmid:24494683
|
Maccarrone M et al. |
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. |
2002 |
Eur. J. Neurosci. |
pmid:11982628
|
Holt S et al. |
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. |
2007 |
Eur. J. Pharmacol. |
pmid:17397826
|
Rodella LF et al. |
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation. |
2005 |
Eur. J. Pharmacol. |
pmid:15680264
|
Stengel PW et al. |
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. |
1998 |
Eur. J. Pharmacol. |
pmid:9754939
|
Wallace MJ et al. |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. |
2002 |
Eur. J. Pharmacol. |
pmid:12359270
|
Kelley BG and Thayer SA |
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15288572
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Orliac ML et al. |
Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17482593
|
McQueen DS et al. |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. |
2004 |
Eur. J. Pharmacol. |
pmid:15140635
|
Fowler CJ et al. |
Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle. |
2004 |
Eur. J. Pharmacol. |
pmid:15145699
|
Mendizábal VE et al. |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. |
2001 |
Eur. J. Pharmacol. |
pmid:11567656
|
Bermúdez-Siva FJ et al. |
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16423347
|
Shimasue K et al. |
Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. |
1996 |
Eur. J. Pharmacol. |
pmid:8904088
|
Lau AH and Chow SS |
Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. |
2003 |
Eur. J. Pharmacol. |
pmid:12620517
|
Peroni RN et al. |
Participation of CGRP and prostanoids in the sex-linked differences of vascular anandamide effects in mesenteric beds of Sprague-Dawley rats. |
2007 |
Eur. J. Pharmacol. |
pmid:17169358
|
Russo R et al. |
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. |
2007 |
Eur. J. Pharmacol. |
pmid:17434479
|
Gifford AN et al. |
Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). |
1999 |
Eur. J. Pharmacol. |
pmid:10556675
|
Zaniewska M et al. |
Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16730696
|
Randall MD et al. |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. |
1997 |
Eur. J. Pharmacol. |
pmid:9314035
|
Wise LE et al. |
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. |
2007 |
Eur. J. Pharmacol. |
pmid:17217945
|
Lay L et al. |
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
2000 |
Eur. J. Pharmacol. |
pmid:10720647
|
Sordelli MS et al. |
Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus. |
2012 |
Eur. J. Pharmacol. |
pmid:22554772
|
Calignano A et al. |
Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. |
1997 |
Eur. J. Pharmacol. |
pmid:9537804
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|